Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 275 entries
View as:

A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device

Phase: N/A Priority: Normal
NCT ID: NCT01791244 Org: User:
Start: 02/28/13 End: 02/29/16 Due: 02/28/17

AS900672-Enriched in Ovulation Induction

Phase: N/A Priority: Normal
NCT ID: NCT00553514 Org: User:
Start: 12/31/07 End: 03/31/09 Due: 03/31/10

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic

Phase: N/A Priority: Normal
NCT ID: NCT01400997 Org: User:
Start: 09/30/11 End: 12/31/15 Due: 12/31/16

A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)

Phase: N/A Priority: Normal
NCT ID: NCT01081756 Org: User:
Start: 12/31/03 End: 09/30/04 Due: 09/30/05

Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study)

Phase: N/A Priority: Normal
NCT ID: NCT00778830 Org: User:
Start: 02/28/09 End: 04/30/14 Due: 04/30/15

A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation

Phase: N/A Priority: Normal
NCT ID: NCT02607293 Org: User:
Start: 12/31/15 End: 06/28/17 Due: 06/28/18

A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age

Phase: N/A Priority: Normal
NCT ID: NCT01075815 Org: User:
Start: 11/30/08 End: 10/31/10 Due: 10/31/11

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy

Phase: N/A Priority: Normal
NCT ID: NCT01439061 Org: User:
Start: 03/31/12 End: 12/31/15 Due: 12/31/16

Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit

Phase: N/A Priority: Normal
NCT ID: NCT01921452 Org: User:
Start: 10/31/13 End: 02/28/14 Due: 02/28/15

Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT00157209 Org: User:
Start: 08/31/00 End: 07/31/12 Due: 07/31/13

A Study to Evaluate the Ease of Use, Local Tolerance, Safety and Effectiveness of Gonal-f® (Filled-by-mass in a Prefilled Pen)

Phase: N/A Priority: Normal
NCT ID: NCT01115725 Org: User:
Start: 11/30/05 End: 07/31/08 Due: 07/31/09

Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02316197 Org: User:
Start: 12/31/14 End: 06/29/17 Due: 06/29/18

Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)

Phase: N/A Priority: Normal
NCT ID: NCT00125034 Org: User:
Start: 07/31/05 End: 11/30/10 Due: 11/30/11

Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina

Phase: N/A Priority: Normal
NCT ID: NCT01080014 Org: User:
Start: 08/31/08 End: 04/30/13 Due: 04/30/14

Effect of a Proton Pump Inhibitor on the PK of Tepotinib

Phase: N/A Priority: Normal
NCT ID: NCT03531762 Org: User:
Start: 05/14/18 End: 07/02/18 Due: 07/02/19

Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™

Phase: N/A Priority: Normal
NCT ID: NCT02254304 Org: User:
Start: 12/31/14 End: 08/20/16 Due: 08/20/17

Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France

Phase: N/A Priority: Normal
NCT ID: NCT01197183 Org: User:
Start: 10/31/08 End: 09/30/09 Due: 09/30/10

A Post Marketing Assessment of Gonal f Solution for Injection in a Prefilled Pen for Follicular Stimulation in in Vitro Fertilisation/Embryo Transfer (IVF-ET) Cycles

Phase: N/A Priority: Normal
NCT ID: NCT01125462 Org: User:
Start: 02/28/11 End: 01/31/12 Due: 01/31/13

A Prospective, Observational Study to Assess and Evaluate the Use of Glucophage XR Therapy in the Management of Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01117103 Org: User:
Start: 01/31/08 End: 01/31/09 Due: 01/31/10

Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice Forielle

Phase: N/A Priority: Normal
NCT ID: NCT03387059 Org: User:
Start: 01/12/18 End: 06/12/18 Due: 06/12/19

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia

Phase: N/A Priority: Normal
NCT ID: NCT01309555 Org: User:
Start: 04/30/11 End: 10/31/16 Due: 10/31/17

A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism

Phase: N/A Priority: Normal
NCT ID: NCT01084265 Org: User:
Start: 02/29/04 End: 12/31/05 Due: 12/31/06

Retrospective Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT03584321 Org: User:
Start: 09/13/17 End: 07/11/18 Due: 07/11/19

A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT01177956 Org: User:
Start: 12/31/09 End: 11/30/12 Due: 11/30/13

A Multicenter Study of rhFGF 18 in Patients With Knee Osteoarthritis Not Requiring Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01033994 Org: User:
Start: 10/31/08 End: 12/31/10 Due: 12/31/11